Vitamin D3 supplementation reduced diabetes risk only in adults with prediabetes carrying specific vitamin D receptor genotypes in this genetic analysis of the D2d trial. Participants with ApaI AC or CC genotypes had a 19% lower risk of diabetes with supplementation, while those with the AA genotype derived no benefit, supporting a role for genotype-guided prevention.

Source: JAMA Network Open